Wellesley Investment Partners’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-6,224
Closed -$303K 128
2018
Q2
$303K Sell
6,224
-8,130
-57% -$461K 0.11% 100
2018
Q1
$899K Buy
14,354
+49
+0.3% +$3.36K 0.32% 57
2017
Q4
$876K Buy
14,305
+1,834
+15% +$113K 0.33% 58
2017
Q3
$834K Sell
12,471
-643
-5% -$45.5K 0.34% 54
2017
Q2
$1.02M Buy
13,114
+567
+5% +$42.8K 0.43% 40
2017
Q1
$1.02M Buy
12,547
+887
+8% +$69.8K 0.45% 34
2016
Q4
$839K Buy
11,660
+3,421
+42% +$247K 0.41% 43
2016
Q3
$640K Buy
8,239
+1,448
+21% +$117K 0.33% 55
2016
Q2
$529K Buy
6,791
+773
+13% +$61.6K 0.29% 56
2016
Q1
$493K Buy
6,018
+505
+9% +$41.1K 0.3% 60
2015
Q4
$492K Buy
+5,513
New +$468K 0.34% 56

Other funds holding CAH

Wellesley Investment Partners's CAH Position: Q3 2018 in Review

Wellesley Investment Partners sold out of Cardinal Health (CAH) in Q3 2018, closing a stake of 6,224 shares — an estimated $303K sold.

Wellesley Investment Partners first reported a position in CAH in Q4 2015 and held it in 11 quarters. The position peaked at $1.02M in Q1 2017. 685 funds tracked by Wall St. Rank hold CAH as of Q3 2018.

  • Wellesley Investment Partners reported no remaining Cardinal Health position as of Q3 2018 after selling out during the quarter.
  • Wellesley Investment Partners sold 6,224 Cardinal Health shares in Q3 2018, an estimated $303K.
  • Wellesley Investment Partners first reported a position in Cardinal Health in Q4 2015 and held it in 11 quarters.
  • Wellesley Investment Partners's Cardinal Health position peaked at $1.02M in Q1 2017.
  • 685 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2018.

Based on Wellesley Investment Partners's 13F filing for Q3 2018, filed 13 Nov 2018.